Unmasking Patient Subtypes in Sjögren’s Disease to Enable Personalized Care
Efgartigimod Shows Early Promise for Primary Sjögren’s Disease
Rethinking Opioids: Key Considerations for Balancing Pain Management and Patient Risk
Martin Cheatle, PhD
Tailoring Approaches to Pediatric Rheumatic Disease: Best Practices for Long-Term Management
John Bridges, MD, MS
Unmasking IgG4-Related Disease: Best Practices for Accurate Diagnosis and Optimal Care
Matthew Baker, MD, MS
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Laura Cappelli, MD, MHS,MS
Evaluating the Safety of Ixekizumab in Psoriasis and Arthritis Patients
Atul A. Deodhar, MD, MRCP
Psoriasis and Arthritis Care: Examining the Impact of Unmet Needs
Navigating Treatment Decisions for Rheumatoid Arthritis: Key Factors to Consider
Robin Dore, MD
Consequences of COVID-19: Addressing Infection-Associated Chronic Conditions
Leonard H. Calabrese, DO
Enhancing Lupus Nephritis Outcomes: The Potential Impact of Lower Glucocorticoid Doses
Treating Skin Manifestations of Connective Tissue Diseases
The Aryl Hydrocarbon Receptor and Lupus: Diagnostic and Therapeutic Advancements
Gates B. Colbert, MD
Deepak Rao, MD, PhD
AI for Rheumatology: Enhancing Imaging Efficiency and Insights
Amanda Nelson, MD
Ultrasound in Osteoarthritis: An Accessible Tool for Early Assessment
Heart Disease in Lupus: The Impact of Rural Residence on Hospitalizations
Jasvinder Singh, MD
Loading...
We're glad to see you're enjoying Rheumatology Academy… but how about a more personalized experience?
Press cancel to remain on Rheumatology Academy. Press the link below or the continue button to keep going.